55
https://pubmed.ncbi.nlm.nih.gov/38116549
A newly synthesized zinc-based metal-organic framework shows potential as a low-toxicity drug carrier for tumor treatment, exhibiting pH-sensitive drug release and high antitumor activity against HepG2 cells.